Effect of the three-drug regimen of H. Pylori eradication with and without probiotics on the eradication treatment

Phase 3

• Conditions: H. Pylori infection.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20120215009014N344
• Lead Sponsor: Hamedan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Age of 18 to 65 years,
H. pylori infection,

Exclusion Criteria

Pregnancy or breastfeeding,
Gastric cancer,
Kidney or liver failure,
History of gastric surgery,
Previous history of Helicobacter pylori treatment,

Study & Design

• Study Type: interventional
• Study Design: Not specified